summary: FTY720 (Fingolimod) is a new therapy that reduces disease activity by decreasing numbers of a specific immune system cell. The authors investigated patients who discontinued therapy during clinical investigation and they found that the reconstitution of this specific cell-type after prolonged FTY720 therapy can be significantly greater than predicted.

authors: Johnson TA, Shames I, Keezer M, Lapierre Y, Haegert DG, Bar-Or A, Antel J.

source: Clin Immunol. 2010 Jul 2

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: